In creating new financial regulations, we need to take the medical analogy one step further – by creating the equivalent of the prescription. Instead of banning or freely allowing all dangerous products, we need to identify products that are valuable to some customers but not all – call them “prescription financial products” – and create a body of registered finance professionals (RFPs) who are empowered to certify the purchase of these products by individuals.